B. Riley Weighs in on Abacus Life's Q1 Earnings (NASDAQ:ABL)

Abacus Life, Inc. (NASDAQ:ABL - Free Report) - B. Riley decreased their Q1 2025 earnings per share (EPS) estimates for shares of Abacus Life in a report released on Wednesday, April 9th. B. Riley analyst R. Binner now anticipates that the company will post earnings of $0.14 per share for the quarter, down from their prior forecast of $0.15. B. Riley has a "Buy" rating and a $15.00 price target on the stock. The consensus estimate for Abacus Life's current full-year earnings is $0.62 per share. B. Riley also issued estimates for Abacus Life's Q2 2025 earnings at $0.16 EPS and Q4 2025 earnings at $0.26 EPS.

Separately, Piper Sandler decreased their target price on Abacus Life from $13.00 to $11.50 and set an "overweight" rating on the stock in a research report on Tuesday, April 8th. Five equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Abacus Life currently has a consensus rating of "Buy" and a consensus price target of $14.00.

Abacus Life Price Performance

Shares of Abacus Life stock traded down $0.11 during trading hours on Thursday, reaching $7.98. The stock had a trading volume of 228,838 shares, compared to its average volume of 163,409. The stock's 50 day moving average is $7.50 and its 200 day moving average is $8.02. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.65. Abacus Life has a twelve month low of $6.34 and a twelve month high of $12.45. The firm has a market capitalization of $772.89 million, a PE ratio of -44.33 and a beta of 0.16.

Remove Ads

Abacus Life (NASDAQ:ABL - Get Free Report) last released its earnings results on Thursday, March 27th. The company reported $0.16 EPS for the quarter, topping analysts' consensus estimates of $0.13 by $0.03. The company had revenue of $33.21 million during the quarter, compared to analysts' expectations of $28.76 million. Abacus Life had a negative net margin of 11.65% and a positive return on equity of 12.88%.

Institutional Trading of Abacus Life

A number of large investors have recently made changes to their positions in the company. Charles Schwab Investment Management Inc. purchased a new stake in shares of Abacus Life in the 3rd quarter valued at approximately $614,000. Geode Capital Management LLC increased its holdings in Abacus Life by 439.6% in the third quarter. Geode Capital Management LLC now owns 171,917 shares of the company's stock valued at $1,741,000 after buying an additional 140,054 shares during the last quarter. Franklin Resources Inc. raised its stake in Abacus Life by 3.6% in the third quarter. Franklin Resources Inc. now owns 437,733 shares of the company's stock valued at $4,382,000 after buying an additional 15,308 shares in the last quarter. Principal Financial Group Inc. lifted its holdings in Abacus Life by 7.9% during the 3rd quarter. Principal Financial Group Inc. now owns 1,011,143 shares of the company's stock worth $10,233,000 after buying an additional 74,172 shares during the last quarter. Finally, Geneos Wealth Management Inc. acquired a new position in shares of Abacus Life during the 4th quarter worth about $110,000.

Abacus Life Company Profile

Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.